Wednesday 1 May | |
Anexo Group PLC | Full Year Results |
Cambridge Cognition Holdings PLC | Full Year Results |
Computacenter PLC | Trading Statement |
Georgia Capital PLC | Q1 Results |
GSK PLC | Q1 Results |
Haleon PLC | Trading Statement |
HSS Hire Group PLC | Full Year Results |
Intelligent Ultrasound Group PLC | Full Year Results |
Maintel Holdings PLC | Full Year Results |
Next PLC | Trading Statement |
Smith & Nephew PLC | Trading Statement |
Thursday 2 May | |
Endeavour Mining PLC | Q1 Results |
First Tin PLC | Trading Statement |
Hiscox Ltd | Trading Statement |
International Personal Finance PLC | Trading Statement |
Kerry Group PLC | Trading Statement |
Lancashire Holdings Ltd | Trading Statement |
Melrose Industries PLC | Trading Statement |
NAHL Group PLC | Full Year Results |
Reach PLC | Trading Statement |
Shell PLC | Q1 Results |
Smiths News PLC | Half Year Results |
Smurfit Kappa Group PLC | Trading Statement |
Spectris PLC | Trading Statement |
Standard Chartered PLC | Q1 Results |
TI Fluid Systems PLC | Q1 Results |
Friday 3 May | |
InterContinental Hotels Group PLC | Trading Statement |
Mondi PLC | Trading Statement |
Trainline PLC | Full Year Results |
Monday 6 May | |
no events scheduled | |
Tuesday 7 May | |
Arecor Therapeutics PLC | Full Year Results |
BP PLC | Q1 Results |
Ebiquity PLC | Full Year Results |
IWG PLC | Trading Statement |
Kosmos Energy Ltd | Q1 Results |
MaxCyte Inc | Q1 Results |
Trident Royalties PLC | Trading Statement |
Vaalco Energy Inc | Q1 Results |
Comments and questions to newsroom@alliancenews.com | |
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional. | |
Copyright 2024 Alliance News Ltd. All Rights Reserved. |
![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
IN BRIEF: MaxCyte CEO Maher Masoud buys 100,000 shares
MaxCyte Inc - Rockville, Maryland-based provider of cell engineering platform technologies - Says Chief Executive Officer Maher Masoud acquired 100,000 shares in the company between Friday and Monday. Masoud purchased the shares at an average of 489.07 US cents each in New York on the open market. These comprise his entire shareholding so far in MaxCyte, giving him an approximate 0.1% stake. Masoud, who became CEO in January, also holds a further 1.1 million options over MaxCyte's common stock and 400,000 performance stock units.
Read more